Canaan Partners

Glooko develops a remote patient-monitoring platform for individuals with diabetes. It integrates with diabetes devices, fitness wearables, and activity trackers to capture data and provide reports, aiming to drive behavior change and improve health outcomes. The platform facilitates communication between patients and healthcare providers, enhancing care. Glooko is available on Android and iOS.

ContentSquare is a digital experience insights optimization platform that helps businesses analyze customer behavior through vast amounts of anonymous web, mobile, and app interactions, adhering to data privacy regulations such as the EU GDPR and California CCPA. By integrating diverse data sets, including content, user experience, product offerings, pricing, acquisition channels, and technical performance, the platform generates insights and AI-driven recommendations to enhance digital performance throughout the customer journey. Its solutions enable clients to better understand user interactions, measure content effectiveness, and clarify consumer intentions, ultimately leading to increased revenue and engagement while reducing operational costs. ContentSquare serves over 700 enterprise clients, including notable brands like American Express, Best Buy, and LVMH.

Relievant Medsystems, Inc. is a medical device company focused on developing innovative solutions for chronic axial low back pain. Founded in 2004 and headquartered in Minneapolis, Minnesota, with a development office in Sunnyvale, California, the company has created the Intracept System. This minimally invasive procedure specifically targets the basivertebral nerve, providing relief by blocking pain signal transmission. The Intracept System offers patients a low-risk therapy option aimed at alleviating chronic vertebrogenic low back pain.

N-Trig is a startup specializing in the development of touch screen technologies and pen styluses, aimed at enhancing user interaction with mobile computing devices. Founded in 1999, the company boasts a robust patent portfolio and offers its products across various sectors, including consumer electronics, education, healthcare, graphic design, gaming, and multimedia. N-Trig's Duosense active pen allows users to annotate on screens in a manner akin to writing on paper, while its multi-touch capabilities facilitate direct interaction with devices. The company operates globally, with its research and development center, corporate headquarters, and management based in Kfar Saba, Israel, alongside sales and support offices in Austin, Texas, and San Jose, California. Additionally, N-Trig has operational and supply chain support in Taipei, Tokyo, and Shanghai.

Xirrus, Inc., established in 2004 and headquartered in Thousand Oaks, California, specializes in wireless access network solutions. It offers a range of products including high-density and outdoor access points, wired switches, network accessories like enclosures and mountings, and power options. Xirrus also provides software solutions such as the Xirrus Management System for network deployment and management, EasyPass Personal Wi-Fi for secure public Wi-Fi access, Wi-Fi Designer for predictive heat-map network design, and XA4 for high-density user experiences in large venues. Serving clients across enterprise, education, healthcare, hospitality, and other markets both domestically and internationally, Xirrus operates as a subsidiary of Riverbed Technology, Inc., focusing on delivering robust wireless networking solutions.

Chimerix, Inc. is a biopharmaceutical company based in Durham, North Carolina, focused on the development of innovative medicines for patients with cancer and serious viral infections. The company is advancing several clinical-stage programs, including dociparstat sodium (DSTAT), a glycosaminoglycan compound aimed at improving outcomes for patients with acute myeloid leukemia during chemotherapy. Another key candidate is brincidofovir (BCV), an antiviral drug being developed as a medical countermeasure for smallpox. Chimerix also leads the development of CMX001, a broad-spectrum antiviral agent targeting life-threatening double-stranded DNA viral infections, currently undergoing multiple clinical studies for use in immunocompromised patients. Additionally, CMX157, an antiviral compound with activity against HIV and hepatitis B, is in development, addressing challenges posed by existing therapies. The company collaborates with various organizations for research and commercialization, deriving revenue from licensing agreements and royalties. Founded in 2000, Chimerix is committed to transforming patient care through its advanced therapeutic candidates.

EndoGastric Solutions, Inc. is a medical device company focused on developing and commercializing innovative surgical technologies for the treatment of gastrointestinal diseases, particularly gastroesophageal reflux disease (GERD). The company offers products such as EsophyX, which enables transoral reconstructive surgery, and the EsophyX Z device used in the transoral incisionless fundoplication procedure. Additionally, EndoGastric Solutions provides SerosaFuse Fasteners, a non-resorbable polypropylene material with strength comparable to traditional sutures. Beyond its product offerings, the company supports healthcare professionals through trainer-led courses and various consultative services, including pre-authorization and medical review. Founded in 2002 and headquartered in Redmond, Washington, with an additional office in San Mateo, California, EndoGastric Solutions was previously known as EsophyX, Inc. before its rebranding in January 2005.

Dexterra is a mobile platform and application provider, with complete solutions to manage and optimize your mobile workforce. Dexterra Concert, its mobile platform provides and open standards-based development environment that supports applications running on all types of mobile devices, integrated with most common back-office systems, and deployed in numerous countries and languages around the world. Its portfolio of mobile applications support field service, scheduling, dispatch, mobile tracking, field sales, asset management and location-based services. Business leaders in a variety of industries depend on Dexterra to mobile their operations, such as ADP, Ikon, Parts Associates, Safelite Autoglass, Tennant, Virgin Media, Verizon and Vodafone.

Aperto Networks is a manufacturer of versatile and cost-effective carrier-grade WiMAX infrastructure equipment, serving service providers and enterprises globally. The company specializes in producing wireless broadband base stations, subscriber units, and element management systems, with a focus on 802.16d, 802.16e, and 802.11n broadband standards. Their flagship product, the PacketMAX Family, offers voice, data, and video services for fixed WiMAX applications. Additionally, Aperto Networks provides the WaveCenter EMS Pro system for managing wireless broadband networks. Founded in 1999 and headquartered in Pitt Meadows, Canada, the company is known for its award-winning technology that supports a wide range of frequencies and applications, both licensed and unlicensed.

Everdream Corporation is a provider of on-demand desktop management software services, specializing in managed services for compliance and uptime. The company offers a comprehensive suite of software solutions that deliver visibility into hardware and software assets, track software license usage, and automate software distribution to ensure regulatory compliance. Additionally, Everdream provides essential protection against Internet attacks, hackers, and data loss through services such as malware protection, patch management, and online data backup. The company also offers IT support solutions, including on-demand employee service desk options and remote control services. Founded in 1998 and headquartered in Fremont, California, Everdream has operational facilities in Dallas, Texas, and Charlotte, North Carolina. It operates as a subsidiary of Dell Inc.

Immunicon is a developer and manufacturer of proprietary cell-based diagnostic and research products, primarily focusing on cancer detection and monitoring. The company specializes in ultra-high sensitivity cancer detection test kits and next-generation cell analysis instruments. Their technologies, branded as CellTracks, are designed to identify, count, and characterize tumor cells in blood samples, providing physicians with clinically meaningful information earlier than traditional diagnostic methods. A notable collaboration with Veridex, a Johnson & Johnson company, has led to the submission of a pre-market notification for the CellSearch Epithelial Cell Kit, aimed at enhancing the management of metastatic breast cancer. Immunicon believes its technologies not only hold promise for cancer diagnostics but may also be applicable in other medical fields, including cardiovascular and infectious diseases, thereby contributing to the advancement of medical research and treatment.